Japanese Journal of Clinical Oncology Advance Access published online on May 10, 2005
Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hyi078
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Urology, Shikoku Cancer Center, Matuyama, Japan
* To whom correspondence should be addressed. Background: We assessed predictors of response to salvage radiotherapy (sRT) in patients with prostate-specific antigen (PSA) recurrence after radical prostatectomy. Methods: A total of 21 patients receiving sRT for PSA recurrence without systemic progression after radical prostatectomy had medical records available for retrospective review. We defined sRT as external beam radiotherapy for patients with a continuous increase in PSA level Results: The median follow-up period after sRT was 38 months. Of the 21 patients, 15 were good responders (71%). The only predictive factor was PSA doubling time (PSADT). Age and PSA level at diagnosis, Gleason score and surgical margin status were not significant predictors of response. The median PSADT in responders was 6.2 months versus 1.9 months in non-responders (P = 0.019). The patients with a PSADT of Conclusion: PSADT appears to be a good predictor of response to sRT. sRT was especially effective when PSADT was
Received February 24, 2005
Accepted March 21, 2005
Original Article
Predictor of Response to Salvage Radiotherapy in Patients with PSA Recurrence after Radical Prostatectomy: the Usefulness of PSA Doubling Time
Kousaku Numata, E-mail: knumata{at}shikoku-cc.go.jp
![]()
Abstract
0.2 ng/ml after radical prostatectomy. Response was defined as achievement of a PSA nadir of
0.1 ng/ml. Various pre-treatment parameters were evaluated retrospectively.
5 months were all responders.
5 months.![]()
CiteULike
Connotea
Del.icio.us What's this?